Quick Answer
Nutex Health Inc. reported Earnings Per Share Diluted of $10.48 per share for the year ending 2025.
- Nutex Health Inc. showed an increase of +8.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Nutex Health Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.05 per share | Q3 2021: $0.09 per share | Q1 2022: $0.04 per share | Q2 2022: $0.03 (loss) per share | Q3 2022: $0.62 (loss) per share | Q4 2022: $0.02 (loss) per share | Q1 2023: $0.12 (loss) per share | Q2 2023: $0.79 (loss) per share | Q3 2023: $1.25 (loss) per share | Q4 2023: $7.47 (loss) per share | Q1 2024: $0.08 (loss) per share | Q2 2024: $0.07 (loss) per share | Q3 2024: $1.72 (loss) per share | Q4 2024: $11.12 per share | Q1 2025: $2.56 per share | Q2 2025: $2.95 (loss) per share | Q3 2025: $7.76 per share.
- Over the full 6 years of available data (2020 to 2025), Nutex Health Inc.'s Earnings Per Share Diluted has grown by 5,722.2%.
- Historical annual values: Fiscal year 2025: $10.48 per share | Fiscal year 2024: $9.69 per share | Fiscal year 2023: $10.39 (loss) per share | Fiscal year 2022: $100.36 (loss) per share | Fiscal year 2021: $0.22 per share | Fiscal year 2020: $0.18 per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: